Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Allogeneic Adoptive Immunochemotherapy For Treatment Of Renal Cell Carcinoma

NCT00073879 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00073879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Allogeneic Adoptive Immunochemotherapy For Treatment Of Renal Cell Carcinoma
Lead sponsor
Baylor College of Medicine
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2003
Completion date
April 30, 2004
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer